首页 > 市场调查报告书 > 医疗设备

生技设备

生物分析检测服务市场规模、份额和成长分析（按分子、检测、工作流程、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900246

生物分析检测服务市场规模、份额和成长分析（按分子、检测、工作流程、应用、最终用途和地区划分）－2026-2033年产业预测

Bioanalytical Testing Services Market Size, Share, and Growth Analysis, By Molecule (Small Molecule, Large Molecule), By Test (ADME, PK), By Workflow, By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球生物分析测试服务市场规模预计在 2024 年达到 41.8 亿美元，从 2025 年的 48.6 亿美元增长到 2033 年的 161.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 16.2%。

全球生物分析检测服务市场为製药和生物技术公司提供评估药物和生物製药安全性和有效性的关键分析服务。这些服务在药物研发和监管核准过程中至关重要，主要着重于检测血液、尿液和组织等生物样本中的药物浓度、代谢物和生物标记。该市场由受託研究机构(CRO) 和其他服务供应商组成，他们为业界提供可靠的检测解决方案。儘管对准确可靠的生物分析检测的需求不断增长，但该市场仍面临着高昂的服务成本和缺乏标准化调查方法等挑战。克服这些障碍对于有效地将安全有效的治疗方案推向市场至关重要。

全球生物分析检测服务市场驱动因素

全球生物分析检测服务市场的主要驱动力是药物研发和核准流程需求的不断增长，而这又源自于製药和生技公司为确保产品安全性和有效性所做的努力。慢性病发病率的上升以及对个人化医疗的需求也在推动这一需求，促使企业投资于先进的调查方法。此外，监管机构对药物检测和生物分析检验的严格要求也促进了市场成长。创新技术和自动化在检测流程中的应用也提高了效率，促使更多机构将这些专业服务外包。

限制全球生物分析检测服务市场的因素

生物分析检测，尤其是高阶和专业检测的高昂成本，对市场构成重大挑战。这种经济负担会阻碍中小型製药公司和研究机构的发展，限制其投资必要检测服务的能力。由于这些小规模机构通常预算紧张，这种经济压力会导致产业创新减少和研发週期延长。因此，生物分析检测的高成本可能成为影响全球生物分析检测服务市场整体成长和发展的障碍。

全球生物分析检测服务市场趋势

受生物标誌物发现和开发技术的进步推动，全球生物分析检测服务市场正经历显着成长。随着医疗重心向个人化转变，生物标记的识别和检验已成为改善早期诊断和实现标靶治疗的关键要素。最尖端科技和调查方法的融合进一步推动了这一趋势，使生物分析检测服务能够更好地满足市场对创新治疗方法和诊断解决方案日益增长的需求。因此，随着企业寻求利用这些进步来改善患者预后并简化药物研发流程，该市场正经历强劲扩张。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Charles River Laboratories（USA）
Labcorp Drug Development（USA）
Eurofins Scientific（Luxembourg）
SGS SA（Switzerland）
PPD, Inc.
ICON plc（Ireland）
Syneos Health（USA）
Q2 Solutions（USA）
Intertek Group plc（UK）
Parexel International Corporation（USA）
ACM Global Laboratories（USA）
Frontage Laboratories, Inc.（USA）
BioAgilytix（USA）
KCAS Bioanalysis & Biomarker Services（USA）
Pacific BioLabs（USA）

结论与建议

简介目录

Product Code: SQMIG35D2157

Global Bioanalytical Testing Services Market size was valued at USD 4.18 Billion in 2024 and is poised to grow from USD 4.86 Billion in 2025 to USD 16.14 Billion by 2033, growing at a CAGR of 16.2% during the forecast period (2026-2033).

The global bioanalytical testing services market encompasses analytical offerings essential for pharmaceutical and biotech companies to evaluate the safety and efficacy of drugs and biologics. These services are vital during drug development and regulatory approval, focusing on measuring drug concentrations, metabolites, and biomarkers in biological samples such as blood, urine, and tissue. This market consists of contract research organizations (CROs) and other service providers that support the industry with reliable testing solutions. While the demand for accurate and dependable bioanalytical testing is increasing, the market faces challenges such as high service costs and a lack of standardization in methodologies. Addressing these barriers is crucial for ensuring the efficient progression of safe and effective therapeutic options to market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioanalytical Testing Services Market

The global bioanalytical testing services market is primarily driven by the increasing demand for drug development and approval processes, as pharmaceutical and biotechnology companies seek to ensure the safety and efficacy of their products. The rise in chronic diseases and the need for personalized medicine further fuel this demand, encouraging firms to invest in advanced testing methodologies. Additionally, regulatory agencies' stringent requirements for drug testing and bioanalytical validation amplify the market's growth. The integration of innovative technologies and automation in testing procedures also enhances efficiency, thereby attracting more organizations to outsource these specialized services.

Restraints in the Global Bioanalytical Testing Services Market

The considerable expenses linked to bioanalytical testing, particularly for advanced and specialized assessments, pose a significant challenge for the market. Such financial burdens can hinder the progress of small pharmaceutical companies and research institutions, limiting their ability to invest in necessary testing services. This financial strain may lead to reduced innovation and slower development timelines within the industry, as these smaller entities often operate on tighter budgets. Consequently, the high costs of bioanalytical testing can create obstacles that impact the overall growth and advancement of the global bioanalytical testing services market.

Market Trends of the Global Bioanalytical Testing Services Market

The Global Bioanalytical Testing Services market is experiencing significant growth driven by advances in biomarker discovery and development. As the focus shifts towards personalized medicine, the identification and validation of biomarkers have emerged as critical components in enhancing early diagnosis and enabling targeted therapies. This trend is further propelled by the integration of cutting-edge technologies and methodologies, allowing bioanalytical testing services to support the burgeoning demand for innovative treatments and diagnostic solutions. Consequently, the market is witnessing a robust expansion as companies seek to leverage these advancements to improve patient outcomes and streamline drug development processes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2026-2033)

Market Overview
Small Molecule
Large Molecule
- LC-MS Studies
- Immunoassays
- PK
- ADA
- Others
Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2026-2033)

Market Overview
ADME
- In-Vivo
- In-Vitro
PK
PD
Bioavailability
Bioequivalence
Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2026-2033)

Market Overview
Pharma & BioPharma Companies
CDMO
CRO

Global Bioanalytical Testing Services Market Size & CAGR (2026-2033)

North America (Molecule, Test, Workflow, Application, End Use)
- US
- Canada
Europe (Molecule, Test, Workflow, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Molecule, Test, Workflow, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Molecule, Test, Workflow, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp Drug Development (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Q2 Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KCAS Bioanalysis & Biomarker Services (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific BioLabs (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments